Obesity, Overweight, Type 2 Diabetes Mellitus
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Body mass index (BMI) between 18.5-34.9 kg / m²; insufficiently active; presence or absence of type 2 diabetes.
Exclusion criteria
Exclusion criteria: Disapproval on physical and cardiological examination; presence of certains disease(coronary artery disease, severe arterial hypertension, chronic obstructive pulmonary disease, limiting osteo-articular diseases) or other general or specific/severe complications of T2DM that may interfere with the results of the research or represent a risk factor to the physical training; Use of exogenous insulin, thiazolidinediones, beta-blockers, anticoagulants to not interfere in the physiological responses to tests or training.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Outcomes will be considered effective if an interaction between group and tpopo (any time measured compared to the pre-intervention moment) with p-value less than 0.05. Molecular characteristics of the subcutaneous fat of the waist region verified by the Real Time technique - Polymerase Chain Reaction (PCR) (fold change);The outcomes will be considered effective even if an interaction between group and tpope (any time measured compared to the pre-intervention moment) with a p-value less than 0.05 is observed. Activity in kilo Becquerel (kBq) and volume in cubic centimeters (cm³) of cervical / scapular brown adipose tissue evaluated by positron emission computed tomography (PET-CT) | — |
Secondary
| Measure | Time frame |
|---|---|
| Increase in physical activity level, evaluated by the IPAQ and Baecke questionnaires (minutes per week) before and after 16 weeks of the experimental period;Improvement in cardiorespiratory fitness assessed by the maximal oxygen consumption test (VO2) by gas analysis (ml / min / kg) before and after 16 weeks of the experimental period;Improvement in quality of life assessed by the WHOQOL-BREF questionnaire (QVG) before and after 16 weeks of the experimental period;Improvement in lifestyle assessed by the "Fantastic" questionnaire (points) before and after 16 weeks of the experimental period;Maintenance of food behavior evaluated by Food Reminders (grams/day of carbohydrates - fat - protein and total kilocalories/day) before and after 16 weeks of the experimental period;Maximum and submaximal strength improvement (kilos) evaluated by the maximum repetition test and 12 maximum repetitions before and after 16 weeks of the experimental period;Anthropometry improve evaluated by weight (kilograms), height (cm), body mass index (BMI) (kg / m²), and waist circumference (cm) before and after 16 weeks of the experimental period;Improvement of body composition using plethysmograph and dual X-ray densitometry (DEXA) for analysis of fat-free mass and fat mass in kilograms (kg) and percentages (%) before and after 16 weeks of the experimental period;Improvement of lung function (total capacity and expired volume) assessed by spirometry before and after 16 weeks of the experimental period;Improvement of clinical biochemical blood markers lipid profile (total cholesterol, triglycerides, HDL, LDL, VLDL (Mg / dl), glucose (mg / dl), glycated hemoglobin (%), blood count (g / dl and mm³), insulin (ui / ml), peptide c (ng / dl), thyroid- TSH (IU / ml) using kits and techniques commercially available before and after 16 weeks of the experimental period;Insulin resistance decrease and insulin sensitivity increase using the index homeostasis model, QUICKI index, TYG index - glucose / tr | — |
Countries
Brazil
Contacts
Faculdade de Educação Física da Universidade Estadual de Campinas